We're pleased to announce the addition of 296 documents obtained by the Project on Government Oversight (POGO) from litigation about Paxil (paroxetine), an antidepressant manufactured by GlaxoSmithKline. POGO investigators found that NIH continues to fund academic researchers who use ghostwriters to write journal articles and other scientific communications.
POGO asked NIH to "implement new policies that will require institutions to ban ghostwriting, and to make NIH funding contingent upon periodic certification from institutions that ghostwriting is strictly prohibited and that enforcement mechanisms such as disciplinary action and dismissal are in place."
The documents can be found here. And more information about the POGO investigation can be found here.